Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;52(8): e8443, 2019. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1011604

RESUMEN

Brain-derived neurotrophic factor (BDNF) is widely expressed in the central nervous system and prolongs the survival of dopaminergic neurons in the substantia nigra. Several studies have recently investigated the association between BDNF G196A (Val66Met), a single nucleotide polymorphism influencing cognitive processes, and cognitive impairment in Parkinson's disease (PD), but with contradictory findings. Thus, this meta-analysis was performed to clarify the possible association. Relevant studies were identified by a systematic search of PubMed, Embase, and China National Knowledge Infrastructure (CNKI) databases. The strength of the association was evaluated using crude odds ratios and 95% confidence interval. Finally, six studies involving 532 cases and 802 controls were included. Our analyses suggested the G196A (Val66Met) polymorphism was significantly associated with cognitive impairment in PD, especially in Caucasian populations. In conclusion, BDNF G196A (Val66Met) is confirmed to be a risk factor for cognitive impairment in PD.


Asunto(s)
Humanos , Masculino , Femenino , Enfermedad de Parkinson/genética , Factor Neurotrófico Derivado del Encéfalo/genética , Disfunción Cognitiva/genética , Enfermedad de Parkinson/complicaciones , Estudios de Casos y Controles , Oportunidad Relativa , Factores de Riesgo , Predisposición Genética a la Enfermedad , Polimorfismo de Nucleótido Simple , Población Blanca , Enfermedad de Alzheimer/complicaciones , Disfunción Cognitiva/complicaciones , Genotipo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA